OLENOX INDUSTRIES INC. (OLOX): Nasdaq/NYSE listing notice — Nasdaq notifies Safe & Green of delisting due to dilution from Series B warrants; company to appeal

OLENOX INDUSTRIES INC.

Nasdaq staff determined to delist SGBX under Rule 5101 over public interest concerns from substantial dilution from Series B warrants issued April 14, 2025.
Company received notification on May 13, 2025; appeal deadline is May 20, 2025; will submit compliance plan to Nasdaq Hearings Panel.
Company also plans to apply for trading on OTCQB market as contingency if delisted.
The delisting basis is additional to any prior deficiencies; Panel will consider at upcoming hearing.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

OLENOX INDUSTRIES INC. received a nasdaq delisting notice notice regarding other (rules 5101).

Exchange: nasdaq
Notice: delisting notice
Rules: 5101

Exact text from the filing

May 13, 2025, Safe & Green Holdings Corp. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), stating that based on its review of the Company’s public filings with the Securities and Exchange Commission (the “SEC”), its staff has determined to delist the Company’s securities pursuant to its discretionary authority under Listing Rule 5101. Specifically, as set forth in the letter, Nasdaq’s staff determined that the Company’s issuance of securities pursuant to the securities purchase agreement dated April 14, 2025

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

OLENOX INDUSTRIES INC. filing history →

Source: SEC EDGAR

accession 0001213900-25-044947

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.